Antiretroviral therapy in adults: updated recommendations of the International AIDS Society–USA Panel
Objective To update recommendations for antiretroviral therapy for adult human
immunodeficiency virus type 1 (HIV-1) infection, based on new information and drugs that …
immunodeficiency virus type 1 (HIV-1) infection, based on new information and drugs that …
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel
PG Yeni, SM Hammer, CCJ Carpenter, DA Cooper… - Jama, 2002 - jamanetwork.com
ObjectiveNew information warrants updated recommendations for the 4 central issues in
antiretroviral therapy: when to start, what drugs to start with, when to change, and what to …
antiretroviral therapy: when to start, what drugs to start with, when to change, and what to …
Increasing burden of liver disease in patients with HIV infection
Introduction of effective combined antiretroviral therapy has made HIV infection a chronic
illness. Substantial reductions in the number of AIDS-related deaths have been …
illness. Substantial reductions in the number of AIDS-related deaths have been …
[HTML][HTML] Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label …
S McCormack, DT Dunn, M Desai, DI Dolling, M Gafos… - The Lancet, 2016 - thelancet.com
Background Randomised placebo-controlled trials have shown that daily oral pre-exposure
prophylaxis (PrEP) with tenofovir–emtricitabine reduces the risk of HIV infection. However …
prophylaxis (PrEP) with tenofovir–emtricitabine reduces the risk of HIV infection. However …
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society–USA panel
SM Hammer, MS Saag, M Schechter, JSG Montaner… - Jama, 2006 - jamanetwork.com
ContextGuidelines for antiretroviral therapy are important for clinicians worldwide given the
complexity of the field and the varied clinical situations in which these agents are used. The …
complexity of the field and the varied clinical situations in which these agents are used. The …
[HTML][HTML] Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
JE Gallant, E DeJesus, JR Arribas… - … England Journal of …, 2006 - Mass Medical Soc
Background Durable suppression of replication of the human immunodeficiency virus (HIV)
depends on the use of potent, well-tolerated antiretroviral regimens to which patients can …
depends on the use of potent, well-tolerated antiretroviral regimens to which patients can …
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel
PG Yeni, SM Hammer, MS Hirsch, MS Saag… - Jama, 2004 - jamanetwork.com
ContextSubstantial changes in the field of human immunodeficiency virus (HIV) treatment
have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral …
have occurred in the last 2 years, prompting revision of the guidelines for antiretroviral …
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome
JC Walsh, S Mandalia, BG Gazzard - Aids, 2002 - journals.lww.com
Objectives Many questionnaires on adherence to antiretroviral therapy are in use, but the
validity of patients' responses has not been tested. The Medication Adherence Self-Report …
validity of patients' responses has not been tested. The Medication Adherence Self-Report …
Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
ME Sharkey, I Teo, T Greenough, N Sharova… - Nature medicine, 2000 - nature.com
Abstract Treatment of HIV-1-infected individuals with a combination of anti-retroviral agents
results in sustained suppression of HIV-1 replication, as evidenced by a reduction in plasma …
results in sustained suppression of HIV-1 replication, as evidenced by a reduction in plasma …
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
Objectives To estimate life expectancy for people with HIV undergoing treatment compared
with life expectancy in the general population and to assess the impact on life expectancy of …
with life expectancy in the general population and to assess the impact on life expectancy of …